SAGE Therapeutics

SAGE Therapeutics

SAGE Therapeutics

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Founded
2011
Raised
$93M
Follow us
Alexa global traffic share
13 Mar 2014
$38,000,000
Venture capital (Series C)
16 Oct 2013
$20,000,000
Venture capital (Series B)
18 Oct 2011
$35,000,000
Venture capital (Series A)